Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00057681
Status:
COMPLETED
Last Update Posted:
2013-04-04
First Post:
2003-04-04
Brief Title:
Study of Outcome and Safety of Lithium Divalproex and Risperidone for Mania in Children and Adolescents
Sponsor:
Washington University School of Medicine
Organization:
Washington University School of Medicine
Study Overview
Official Title:
Treatment of Early Age Mania TEAM Study
Status:
COMPLETED
Status Verified Date:
2013-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TEAM
Brief Summary:
This study will evaluate the effectiveness of the medications lithium Eskalith valproate Depakote and risperidone Risperdal in treating children and adolescents with bipolar disorder or symptoms of mania
Detailed Description:
Patients are randomly assigned to receive lithium Eskalith valproate Depakote or risperidone Risperdal for 8 to 16 weeks They will have weekly visits to monitor their response to the medication When the study is complete care will be transferred to the childs treating psychiatrist
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U01MH064869 | NIH | None | httpsreporternihgovquickSearchU01MH064869 |
| U01MH064846 | NIH | None | None |
| U01MH064911 | NIH | None | None |
| U01MH064868 | NIH | None | None |
| U01MH064887 | NIH | None | None |
| U01MH064850 | NIH | None | None |